Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS): A Pragmatic Trial of Precision Prostate Cancer Screening

NCT05926102 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT05926102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05926102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS): A Pragmatic Trial of Precision Prostate Cancer Screening
Lead sponsor
VA Office of Research and Development
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2024
Completion date
September 30, 2030
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer